カテゴリ： 世界, 医療/バイオ, MarketsandMarkets

世界の軟部組織修復市場（～2027年）：製品別（メッシュ/組織パッチ、同種移植片、異種移植片、縫合糸アンカー、インターフェアレンススクリュー、腹腔鏡器具）、用途別（ヘルニア、硬膜、整形外科、皮膚、歯科、膣、豊胸）

■ 英語タイトル：Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2027

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：MD3215-22）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：MD3215-22
■ 発行日：2022年3月29日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：222
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥742,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,222,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の軟部組織修復市場（～2027年）：製品別（メッシュ/組織パッチ、同種移植片、異種移植片、縫合糸アンカー、インターフェアレンススクリュー、腹腔鏡器具）、用途別（ヘルニア、硬膜、整形外科、皮膚、歯科、膣、豊胸）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

マーケッツアンドマーケッツ社は、世界の軟部組織修復市場規模が、2022年136億ドルから2027年172億ドルまで年平均4.7％成長すると予測しています。本調査資料では、軟部組織修復の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（組織パッチ/メッシュ、腹腔鏡器具）分析、用途別（ヘルニア修復、皮膚修復、整形外科修復、歯科修復、豊胸）分析、エンドユーザー別（病院、クリニック、その他）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の軟部組織修復市場規模：製品別（組織パッチ/メッシュ、腹腔鏡器具）
・世界の軟部組織修復市場規模：用途別（ヘルニア修復、皮膚修復、整形外科修復、歯科修復、豊胸）
・世界の軟部組織修復市場規模：エンドユーザー別（病院、クリニック、その他）
・世界の軟部組織修復市場規模：地域別
・競争状況
・企業情報

“MarketsandMarkets expects the soft tissue repair market is projected to reach USD 17.2Billion by 2027 from USD 13.6Billion in 2022, at a CAGR of 4.7% during the forecast period.”
Growth in this market is mainly driven by Increasing aging population and obesity rate, growing incidence of sports injuries, strong focus on R&D leading to the launch of technologically advanced products, and increasing volume of surgeries and growing prevalence of severe trauma injuries. This, in turn, unfavorable reimbursement scenario and high price of soft tissue repair products and the rising cost of surgical procedures are the key factors restraining the growth of the market. In this report, the soft tissue repair market is segmented on the basis of product, application, end user, and region.
In this report, the soft tissue repair market is segmented on the basis of product, application, end user, and region.

“Tissue Patched/Mashes accounted for the largest share in the soft tissue repair market by product type”
Based on product, soft tissue repair market is segmented into tissue patch/mash and laproscopicintrument injectors. In 2021, Tissue Patch/Mesh accounted for the larger share of 91.9% of the soft tissue repair market. This product segment is projected to reach USD 15,892.3 million by 2027 from 12,547.2 million in 2022, at a CAGR of 4.8% during the forecast period. The large share of this segment is attributed to the increasing use of synthetic Mesh across different types of orthopedic surgeries as they reduce surgical time.

“Hernia Repair accounted for the largest share in the soft tissue repair market by Application”
Based on application type, the soft tissue repair market is segmented into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopedic repair, Dental repair, Breast Reconstruction Repair, and other applications. In 2021, the hernia repair is estimated to account for the largest share of 26.5% of the soft tissue repair market, by application. The increasing incidence of hernia cases, sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), are some of the major factors responsible for the growth in the number of soft tissue repair surgeries performed globally.

“Hospital segment accounted for the largest share in the soft tissue repair market by End User”
Based on end users, the soft tissue repair market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, emergency care centers, burn care centers, and research institutes). The hospitals segment accounted for the largest share of 93.3% of the soft tissue repair market in 2021. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the increasing adoption of soft tissue repair products by surgeons.

“North America segment accounted for the largest share in the soft tissue repair market by Region”
On the basis of region, the soft tissue repair market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of 43.5% of the soft tissue repair market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market is attributed to the presence of an advanced healthcare system in the region, high and growing number of surgical procedures, higher adoption of advanced products, and the presence of several leading market players in the US.

Key Market Players :
Prominent players in the soft tissue repair market include Smith & Nephew Plc. (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic Plc. (IE), LifeNet Health, Inc. (US), Becton, Dickinson and Company (US), Integra LifeSciences Corporation (US), CryoLife, Inc. (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ). These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the soft tissue repair market.

A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:
• By Company Type: Tier 1–5%, Tier 2–15%, and Tier 3–80%
• By Designation: C-level–45%, Director Level–25%, and Others–30%
• By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%

Research Coverage:
The market study covers the soft tissue repair market across various segments. It aims at estimating the market sizeand the growth potential of this market across different segmentsby product, by application, by end user, and by region.The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the soft tissue repairmarket and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

*** レポート目次（コンテンツ）***

1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 MARKETS COVERED – BY REGION 30
1.3.3 YEARS CONSIDERED FOR THE STUDY 31
1.4 CURRENCY 31
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 31
1.5 STAKEHOLDERS 32
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH APPROACH 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 36
2.1.2.1 Primary sources 36
2.1.2.2 Key data from primary sources 37
2.1.2.3 Breakdown of primaries 37
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 38
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020) 39
FIGURE 5 SUPPLY-SIDE ANALYSIS: SOFT TISSUE REPAIR MARKET 40
FIGURE 6 TOP-DOWN APPROACH 41
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE SOFT TISSUE REPAIR MARKET (2022–2027) 42
2.3 GROWTH FORECAST 42
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE SOFT TISSUE
REPAIR MARKET (2021) 43
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.5 KEY INDUSTRY INSIGHTS 45
 
2.6 LIMITATIONS 45
2.6.1 METHODOLOGY-RELATED LIMITATIONS 45
2.7 RISK ASSESSMENT 46
2.8 ASSUMPTIONS FOR THE STUDY 46
3 EXECUTIVE SUMMARY 47
FIGURE 10 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 47
FIGURE 11 SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 48
FIGURE 12 SOFT TISSUE REPAIR MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 48
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE SOFT TISSUE REPAIR MARKET 49
4 PREMIUM INSIGHTS 50
4.1 SOFT TISSUE REPAIR SYSTEM MARKET OVERVIEW 50
FIGURE 14 INCREASING HERNIA CASES AND TRAUMA INJURIES AND
GROWING R&D DRIVE THE MARKET 50
4.2 REGIONAL MIX: SOFT TISSUE REPAIR MARKET 50
FIGURE 15 APAC TO REGISTER THE HIGHEST CAGR OF DURING THE FORECAST PERIOD 50
4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2021) 51
FIGURE 16 TISSUE PATCHES/MESHES ACCOUNTED FOR THE LARGEST SHARE
OF THE ASIA PACIFIC MARKET IN 2021 51
4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
FIGURE 17 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING
THE FORECAST PERIOD 52
4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. DEVELOPING MARKETS 52
FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE
DURING THE FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing aging population and obesity rate 54
5.2.1.2 Growing incidence of sports injuries 54
5.2.1.3 Strong focus on R&D 55
5.2.1.4 Increasing volume of surgeries and growing prevalence of
severe trauma injuries 55
TABLE 2 UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL
PROCEDURES PERFORMED 56
5.2.2 RESTRAINTS 57
5.2.2.1 Unfavorable reimbursement scenario 57
5.2.2.2 High product and procedure costs 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging markets 58
TABLE 3 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD) 58
5.2.3.2 Growing use of combination materials for enhancing product efficacy 59
5.2.4 CHALLENGES 59
5.2.4.1 Stringent regulatory framework 59
5.2.4.2 Need for skilled personnel 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON ECONOMIC SCENARIO IN
SOFT TISSUE REPAIR MARKET 60
5.4 ECOSYSTEM ANALYSIS 61
FIGURE 19 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS 61
5.5 PRICING ANALYSIS 62
TABLE 4 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS 62
5.6 SUPPLY CHAIN ANALYSIS 62
FIGURE 20 SUPPLY CHAIN ANALYSIS: SOFT TISSUE REPAIR MARKET (2021) 62
5.7 PATENT ANALYSIS 64
5.7.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET 64
FIGURE 21 GLOBAL PATENT PUBLICATION TRENDS IN SOFT TISSUE REPAIR, 2016–2021 64
5.7.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS 65
FIGURE 22 TOP COMPANIES THAT APPLIED FOR SOFT TISSUE REPAIR PRODUCT PATENTS, 2016–2021 65
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE SOFT TISSUE REPAIR MARKET 65
FIGURE 23 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SOFT TISSUE REPAIR PATENTS, 2016–2021 65
5.8 VALUE CHAIN ANALYSIS 66
FIGURE 24 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS (2021) 66
5.9 TECHNOLOGY ANALYSIS 67
5.10 KEY CONFERENCES & EVENTS IN 2022–2023 67
5.11 REGULATORY LANDSCAPE 68
TABLE 5 REGULATORY STANDARDS/APPROVALS REQUIRED FOR SOFT TISSUE
REPAIR PRODUCTS, BY COUNTRY/REGION 68
5.12 PORTER’S FIVE FORCES ANALYSIS 68
TABLE 6 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS 68
5.12.1 THREAT FROM NEW ENTRANTS 69
5.12.2 COMPETITIVE RIVALRY 69
5.12.3 BARGAINING POWER OF BUYERS 69
5.12.4 BARGAINING POWER OF SUPPLIERS 70
5.12.5 THREAT FROM SUBSTITUTES 70
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 70
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS 70
TABLE 7 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS (%) 71
 
5.13.2 BUYING CRITERIA 71
FIGURE 26 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 71
TABLE 8 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 72
6 SOFT TISSUE REPAIR MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
TABLE 9 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 74
6.2 TISSUE PATCHES/MESHES 74
TABLE 10 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2020–2027 (USD MILLION) 75
TABLE 11 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION) 75
6.2.1 SYNTHETIC MESHES 76
6.2.1.1 Growing popularity is attributed to the availability of raw materials, lack of infectious disease transmission, cost-effectiveness 76
TABLE 12 SOFT TISSUE REPAIR MARKET FOR SYNTHETIC MESHES, BY COUNTRY,
2020–2027 (USD MILLION) 76
6.2.2 BIOLOGICAL MESHES 77
TABLE 13 SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 14 SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE,
2020–2027 (USD MILLION) 78
6.2.2.1 Allografts 78
6.2.2.1.1 Biocompatibility and superior aesthetic results drive the use of allografts 78
TABLE 15 SOFT TISSUE REPAIR MARKET FOR ALLOGRAFTS, BY COUNTRY,
2020–2027 (USD MILLION) 79
6.2.2.2 Xenografts 79
6.2.2.2.1 Xenografts are more viable than allografts due to availability and size ranges 79
TABLE 16 SOFT TISSUE REPAIR MARKET FOR XENOGRAFTS, BY COUNTRY,
2020–2027 (USD MILLION) 80
6.2.3 FIXATION PRODUCTS 80
TABLE 17 SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 81
TABLE 18 SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 81
6.2.3.1 Suture anchors 82
6.2.3.1.1 Growing injury incidence and need for surgery drive demand for suture anchors 82
TABLE 19 SOFT TISSUE REPAIR MARKET FOR SUTURE ANCHORS, BY COUNTRY,
2020–2027 (USD MILLION) 82
6.2.3.2 Interference screws 83
6.2.3.2.1 Availability of advanced biodegradable screws and development of biocomposites drives the market growth 83
TABLE 20 SOFT TISSUE REPAIR MARKET FOR INTERFERENCE SCREWS, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.2.3.3 Other fixation products 83
TABLE 21 SOFT TISSUE REPAIR MARKET FOR OTHER FIXATION PRODUCTS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.3 LAPAROSCOPIC INSTRUMENTS 84
6.3.1 QUICK RECOVERY, LOW PAIN & INFECTION RATES DRIVE DEMAND FOR LAPAROSCOPIC SURGERY AND ASSOCIATED INSTRUMENTS 84
TABLE 22 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS,
BY COUNTRY, 2020–2027 (USD MILLION) 85
7 SOFT TISSUE REPAIR MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 23 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
7.2 HERNIA REPAIR 87
7.2.1 HERNIA REPAIR ACCOUNTS FOR THE LARGEST SHARE OF
THE SOFT TISSUE REPAIR MARKET 87
TABLE 24 SOFT TISSUE REPAIR MARKET FOR HERNIA REPAIR, BY COUNTRY,
2020–2027 (USD MILLION) 88
7.3 SKIN REPAIR 88
7.3.1 INCREASING CASES OF CHRONIC WOUNDS, DIABETIC ULCERS, AND BURNS CONTRIBUTE TO GROWTH OF SKIN REPAIR MARKET 88
TABLE 25 SOFT TISSUE REPAIR MARKET FOR SKIN REPAIR, BY COUNTRY,
2020–2027 (USD MILLION) 89
7.4 ORTHOPEDIC REPAIR 89
7.4.1 INCREASING NUMBER OF SPORTS INJURIES DRIVES
ORTHOPEDIC REPAIR MARKET 89
TABLE 26 SOFT TISSUE REPAIR MARKET FOR ORTHOPEDIC REPAIR, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.5 DENTAL REPAIR 90
7.5.1 RISING DEMAND FOR PREVENTIVE AND COSMETIC DENTAL PROCEDURES DRIVES THE DENTAL REPAIR MARKET 90
TABLE 27 SOFT TISSUE REPAIR MARKET FOR DENTAL REPAIR, BY COUNTRY,
2020–2027 (USD MILLION) 91
7.6 BREAST RECONSTRUCTION 91
7.6.1 RISING BREAST CANCER PREVALENCE SUPPORTS MARKET GROWTH 91
TABLE 28 SOFT TISSUE REPAIR MARKET FOR BREAST RECONSTRUCTION, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.7 DURAL REPAIR 92
7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS AND AWARENESS DRIVES THE DURAL SOFT TISSUE REPAIR MARKET 92
TABLE 29 SOFT TISSUE REPAIR MARKET FOR DURAL REPAIR, BY COUNTRY,
2020–2027 (USD MILLION) 93
7.8 VAGINAL SLING PROCEDURES 93
7.8.1 DEMAND FOR VAGINAL SLING PROCEDURES BOLSTERED BY GROWING CASES OF STRESS-INDUCED URINARY INCONTINENCE (SUI) IN WOMEN 93
TABLE 30 SOFT TISSUE REPAIR MARKET FOR VAGINAL SLING PROCEDURES,
BY COUNTRY, 2020–2027 (USD MILLION) 94
 
7.9 OTHER APPLICATIONS 94
TABLE 31 SOFT TISSUE REPAIR MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
8 SOFT TISSUE REPAIR MARKET, BY END USER 96
8.1 INTRODUCTION 97
TABLE 32 SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION) 97
8.2 HOSPITALS 97
8.2.1 HOSPITALS ARE THE LARGEST END USERS OF
SOFT TISSUE REPAIR PRODUCTS 97
TABLE 33 SOFT TISSUE REPAIR MARKET FOR HOSPITALS, BY COUNTRY,
2020–2027 (USD MILLION) 98
8.3 CLINICS 98
8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS 98
TABLE 34 SOFT TISSUE REPAIR MARKET FOR CLINICS, BY COUNTRY,
2020–2027(USD MILLION) 99
8.4 OTHER END USERS 99
TABLE 35 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY,
2020–2027 (USD MILLION) 100
9 SOFT TISSUE REPAIR MARKET, BY REGION 101
9.1 INTRODUCTION 102
FIGURE 27 INDIA AND CHINA TO REGISTER HIGHEST GROWTH RATES IN THE
SOFT TISSUE REPAIR MARKET 102
TABLE 36 SOFT TISSUE REPAIR MARKET, BY REGION, 2020–2027 (USD MILLION) 102
9.2 NORTH AMERICA 103
FIGURE 28 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT 104
TABLE 37 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 104
TABLE 38 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 105
TABLE 39 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 40 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 41 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 42 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 106
TABLE 43 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 107
9.2.1 US 107
9.2.1.1 Presence of prominent market players and high per capita income supports market growth in the US 107
TABLE 44 US: MACROECONOMIC INDICATORS 107
TABLE 45 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 108
TABLE 46 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 47 US: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 48 US: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 109
TABLE 49 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 109
TABLE 50 US: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 109
9.2.2 CANADA 110
9.2.2.1 Rising healthcare expenditure and favorable public and private funding supports soft tissue repair market growth 110
TABLE 51 CANADA: MACROECONOMIC INDICATORS 110
TABLE 52 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 110
TABLE 53 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 54 CANADA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 55 CANADA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 56 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 112
TABLE 57 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 112
9.3 EUROPE 112
FIGURE 29 EUROPE: SOFT TISSUE REPAIR MARKET SNAPSHOT 113
TABLE 58 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 114
TABLE 59 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 114
TABLE 60 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 61 EUROPE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 62 EUROPE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 63 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 115
TABLE 64 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 116
9.3.1 GERMANY 116
9.3.1.1 Germany holds the largest share of the European market 116
TABLE 65 GERMANY: MACROECONOMIC INDICATORS 116
TABLE 66 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 117
TABLE 67 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 68 GERMANY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES,
BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 69 GERMANY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 70 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 118
TABLE 71 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 118
9.3.2 FRANCE 119
9.3.2.1 Presence of a well-established healthcare system and growing geriatric population to boost the market growth 119
TABLE 72 FRANCE: MACROECONOMIC INDICATORS 119
TABLE 73 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 119
TABLE 74 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 75 FRANCE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 76 FRANCE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 77 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 121
TABLE 78 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 121
9.3.3 UK 121
9.3.3.1 Growing volume of hernia repair surgeries and cardiovascular surgeries in the UK stimulating market growth 121
TABLE 79 UK: MACROECONOMIC INDICATORS 122
TABLE 80 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 81 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 82 UK: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 83 UK: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 84 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 123
TABLE 85 UK: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 124
9.3.4 ITALY 124
9.3.4.1 Increasing volume of surgeries to drive the demand for soft tissue repair products in the country 124
TABLE 86 ITALY: MACROECONOMIC INDICATORS 124
TABLE 87 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 125
TABLE 88 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 89 ITALY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 90 ITALY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 91 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 126
TABLE 92 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 126
9.3.5 SPAIN 127
9.3.5.1 Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth 127
TABLE 93 SPAIN: MACROECONOMIC INDICATORS 127
TABLE 94 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 128
TABLE 95 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 96 SPAIN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 97 SPAIN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 98 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 129
TABLE 99 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 129
9.3.6 REST OF EUROPE 130
TABLE 100 ROE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 130
TABLE 101 ROE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 102 ROE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 103 ROE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 104 ROE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 132
TABLE 105 ROE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 132
9.4 ASIA PACIFIC 132
FIGURE 30 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT 133
TABLE 106 APAC: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 134
TABLE 107 APAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 134
TABLE 108 APAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 109 APAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 110 APAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 111 APAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 112 APAC: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 136
9.4.1 JAPAN 136
9.4.1.1 Strong healthcare system and rising geriatric population to support market growth in Japan 136
TABLE 113 JAPAN: MACROECONOMIC INDICATORS 137
TABLE 114 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 137
TABLE 115 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 116 JAPAN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 117 JAPAN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 118 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 138
TABLE 119 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 139
9.4.2 CHINA 139
9.4.2.1 Growing number of hospitals and healthcare policy reforms stimulating market growth 139
TABLE 120 CHINA: MACROECONOMIC INDICATORS 140
TABLE 121 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 140
TABLE 122 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 123 CHINA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 124 CHINA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 125 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 141
TABLE 126 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 142
9.4.3 INDIA 142
9.4.3.1 Rising healthcare awareness and favorable government support to stimulate market growth in India 142
TABLE 127 INDIA: MACROECONOMIC INDICATORS 143
TABLE 128 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 143
TABLE 129 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 130 INDIA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 131 INDIA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 132 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 144
TABLE 133 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 145
9.4.4 REST OF ASIA PACIFIC 145
TABLE 134 ROAPAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 145
TABLE 135 ROAPAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 136 ROAPAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 137 ROAPAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 138 ROAPAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 147
TABLE 139 ROAPAC: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 147
9.5 LATIN AMERICA 147
9.5.1 LOW-COST SURGERIES ATTRACT MEDICAL TOURISTS TO LATIN AMERICA 147
TABLE 140 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 148
TABLE 141 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 142 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 143 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 144 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 149
TABLE 145 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 150
9.6 MIDDLE EAST & AFRICA 150
9.6.1 MEA IS THE SMALLEST REGIONAL MARKET FOR BIOSURGERY PRODUCTS 150
TABLE 146 MEA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 151
TABLE 147 MEA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 148 MEA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 149 MEA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 150 MEA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 152
TABLE 151 MEA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION) 152
 
10 COMPETITIVE LANDSCAPE 153
10.1 OVERVIEW 153
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 153
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 154
FIGURE 31 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE
SOFT TISSUE REPAIR MARKET 154
10.4 MARKET SHARE ANALYSIS 155
FIGURE 32 SOFT TISSUE REPAIR MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 155
10.5 COMPANY EVALUATION QUADRANT 156
10.5.1 STARS 156
10.5.2 PERVASIVE PLAYERS 156
10.5.3 EMERGING LEADERS 157
10.5.4 PARTICIPANTS 157
FIGURE 33 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX, 2021 157
10.6 COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS 158
10.6.1 PROGRESSIVE COMPANIES 158
10.6.2 DYNAMIC COMPANIES 158
10.6.3 STARTING BLOCKS 158
10.6.4 RESPONSIVE COMPANIES 158
FIGURE 34 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX
FOR SMES & START-UP 159
10.7 COMPETITIVE BENCHMARKING 160
10.7.1 OVERALL COMPANY FOOTPRINT 160
TABLE 152 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 160
TABLE 153 COMPANY FOOTPRINT: BY PRODUCT (25 COMPANIES) 161
TABLE 154 COMPANY FOOTPRINT: BY APPLICATION (25 COMPANIES) 162
TABLE 155 COMPANY FOOTPRINT: BY REGION (25 COMPANIES) 163
10.8 COMPETITIVE SCENARIO 165
10.8.1 DEALS 165
TABLE 156 DEALS 165
10.8.2 OTHER DEVELOPMENTS 166
TABLE 157 OTHER DEVELOPMENTS 166
11 COMPANY PROFILES 167
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 KEY PLAYERS 167
11.1.1 ARTHREX INC. 167
TABLE 158 ARTHREX INC.: BUSINESS OVERVIEW 167
11.1.2 SMITH & NEPHEW PLC 169
TABLE 159 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 169
FIGURE 35 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020) 170
11.1.3 JOHNSON & JOHNSON 173
TABLE 160 JOHNSON & JOHNSON: BUSINESS OVERVIEW 173
FIGURE 36 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020) 174
11.1.4 BECTON, DICKINSON & COMPANY 177
TABLE 161 BECTON, DICKINSON & COMPANY: BUSINESS OVERVIEW 177
FIGURE 37 BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT (2020) 177
11.1.5 STRYKER CORPORATION 181
TABLE 162 STRYKER CORPORATION: BUSINESS OVERVIEW 181
FIGURE 38 STRYKER CORPORATION: COMPANY SNAPSHOT (2020) 182
11.1.6 MEDTRONIC PLC. 184
TABLE 163 MEDTRONIC PLC.: BUSINESS OVERVIEW 184
FIGURE 39 MEDTRONIC PLC.: COMPANY SNAPSHOT (2020) 185
11.1.7 ZIMMER BIOMET 188
TABLE 164 ZIMMER BIOMET: BUSINESS OVERVIEW 188
FIGURE 40 ZIMMER BIOMET: COMPANY SNAPSHOT (2020) 189
11.1.8 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 191
TABLE 165 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW 191
FIGURE 41 INTEGRA LIFESCIENCES HOLDINGS CORPORATION:
COMPANY SNAPSHOT (2020) 192
11.1.9 CRYOLIFE INC. 194
TABLE 166 CRYOLIFE INC.: BUSINESS OVERVIEW 194
FIGURE 42 CRYOLIFE INC.: COMPANY SNAPSHOT (2020) 195
11.1.10 ORGANOGENESIS INC. 197
TABLE 167 ORGANOGENESIS INC.: BUSINESS OVERVIEW 197
FIGURE 43 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020) 197
11.2 OTHER PLAYERS 199
11.2.1 LIFENET HEALTH INC. 199
TABLE 168 LIFENET HEALTH INC.: BUSINESS OVERVIEW 199
11.2.2 BAXTER INTERNATIONAL, INC. 201
TABLE 169 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW 201
FIGURE 44 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2020) 202
11.2.3 TISSUE REGENIX GROUP PLC 204
TABLE 170 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW 204
FIGURE 45 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT (2020) 204
11.2.4 CONMED CORPORATION 207
TABLE 171 CONMED CORPORATION: BUSINESS OVERVIEW 207
FIGURE 46 CONMED CORPORATION: COMPANY SNAPSHOT (2020) 208
11.2.5 MERIL LIFE SCIENCES PVT. LTD. 210
TABLE 172 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW 210
11.2.6 RTI SURGICAL 211
TABLE 173 RTI SURGICAL: BUSINESS OVERVIEW 211
11.2.7 SAMYANG HOLDINGS CORPORATION 212
TABLE 174 SAMYANG HOLDINGS CORPORATION: BUSINESS OVERVIEW 212
11.2.8 AROA BIOSURGERY LTD. 213
TABLE 175 AROA BIOSURGERY LTD.: BUSINESS OVERVIEW 213
11.2.9 ACERA SURGICAL INC. 214
TABLE 176 ACERA SURGICAL INC.: BUSINESS OVERVIEW 214
11.2.10 ORTHOCELL LTD. 215
TABLE 177 ORTHOCELL LTD.: BUSINESS OVERVIEW 215
11.2.11 ACELL INC. 216
TABLE 178 ACELL INC.: BUSINESS OVERVIEW 216
11.2.12 BIOCER ENTWICKLUNGS-GMBH 217
TABLE 179 BIOCER ENTWICKLUNGS-GMBH: BUSINESS OVERVIEW 217
11.2.13 ISTO BIOLOGICS 218
TABLE 180 ISTO BIOLOGICS: BUSINESS OVERVIEW 218
11.2.14 BETATECH MEDICAL 219
TABLE 181 BETATECH MEDICAL: BUSINESS OVERVIEW 219
11.2.15 MIMEDX 220
TABLE 182 MIMEDX: BUSINESS OVERVIEW 220
FIGURE 47 MIMEDX: COMPANY SNAPSHOT (2020) 220
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX 222
12.1 INDUSTRY INSIGHTS 222
12.2 DISCUSSION GUIDE 223
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 226
12.4 AVAILABLE CUSTOMIZATIONS 228
12.5 RELATED REPORTS 228
12.6 AUTHOR DETAILS 229



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のメタゲノムシーケンス市場（～2027年）：製品・サービス別（試薬、消耗品、機器）、ワークフロー別（試料調製、シーケンス）、技術別（16S rRNA、ショットガン、全ゲノム）、用途別（創薬、診断）
  • 世界の医薬品用包装機市場（～2027年）：製品別（無菌包装、ブリスター、ストリップ、ボトル、チューブ、カートン、ケースパッカー、ラッピングマシン、パレタイジング、ラベリング＆シリアル化）、種類別（錠剤、粉末、クリーム、シロップ、エアゾール）
  • 世界の海底送電網システム市場（～2027年）：構成別（ケーブル、可変速ドライブ、変圧器、開閉装置）、用途別（自家発電、風力）、深さ別（浅水、深水）、地域別
  • 世界の統合マイクロ波アセンブリ（IMA）市場（～2027年）：製品別（増幅器、周波数シンセサイザー、発振器）、周波数別、産業別（航空、通信、軍事・防衛）、地域別
  • 世界の取引監視システム市場（～2027年）：コンポーネント別（ソリューション（リスク＆コンプライアンス、監視＆分析、ケース管理）、サービス）、展開別、組織規模別、産業別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MD3215-22 )"世界の軟部組織修復市場（～2027年）：製品別（メッシュ/組織パッチ、同種移植片、異種移植片、縫合糸アンカー、インターフェアレンススクリュー、腹腔鏡器具）、用途別（ヘルニア、硬膜、整形外科、皮膚、歯科、膣、豊胸）" (英文：Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2027)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。